TORRENT PHARMACEUTICALS
|
TORRENT PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹169 Cr | ₹169 Cr | ₹85 Cr | ₹85 Cr | ₹85 Cr |
Equity - Authorised | ₹210 Cr | ₹210 Cr | ₹125 Cr | ₹125 Cr | ₹125 Cr |
Equity - Issued | ₹169 Cr | ₹169 Cr | ₹85 Cr | ₹85 Cr | ₹85 Cr |
Equity Paid Up | ₹169 Cr | ₹169 Cr | ₹85 Cr | ₹85 Cr | ₹85 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹6,687 Cr | ₹6,029 Cr | ₹5,868 Cr | ₹5,753 Cr | ₹4,739 Cr |
Securities Premium | - | - | ₹4.34 Cr | ₹4.34 Cr | ₹4.34 Cr |
Capital Reserves | ₹5.56 Cr | ₹5.56 Cr | ₹5.56 Cr | ₹5.56 Cr | ₹5.56 Cr |
Profit & Loss Account Balance | ₹3,942 Cr | ₹3,303 Cr | ₹2,917 Cr | ₹2,806 Cr | ₹1,893 Cr |
General Reserves | ₹2,848 Cr | ₹2,813 Cr | ₹2,857 Cr | ₹2,784 Cr | ₹2,648 Cr |
Other Reserves | ₹-109 Cr | ₹-93 Cr | ₹85 Cr | ₹152 Cr | ₹187 Cr |
Reserve excluding Revaluation Reserve | ₹6,687 Cr | ₹6,029 Cr | ₹5,868 Cr | ₹5,753 Cr | ₹4,739 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹6,856 Cr | ₹6,198 Cr | ₹5,953 Cr | ₹5,837 Cr | ₹4,823 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹1,604 Cr | ₹2,496 Cr | ₹2,123 Cr | ₹2,941 Cr | ₹3,302 Cr |
Non Convertible Debentures | ₹785 Cr | ₹1,273 Cr | ₹1,241 Cr | ₹1,558 Cr | ₹1,705 Cr |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹1,514 Cr | ₹1,926 Cr | ₹1,455 Cr | ₹2,161 Cr | ₹2,985 Cr |
Term Loans - Institutions | - | ₹333 Cr | ₹400 Cr | ₹400 Cr | - |
Other Secured | ₹-696 Cr | ₹-1,036 Cr | ₹-972 Cr | ₹-1,178 Cr | ₹-1,388 Cr |
Unsecured Loans | - | - | - | - | ₹1.56 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | ₹1.56 Cr | ₹3.12 Cr |
Other Unsecured Loan | - | - | - | ₹-1.56 Cr | ₹-1.56 Cr |
Deferred Tax Assets / Liabilities | ₹101 Cr | ₹-142 Cr | ₹-300 Cr | ₹-422 Cr | ₹-433 Cr |
Deferred Tax Assets | ₹956 Cr | ₹1,058 Cr | ₹1,206 Cr | ₹1,383 Cr | ₹1,329 Cr |
Deferred Tax Liability | ₹1,057 Cr | ₹916 Cr | ₹906 Cr | ₹961 Cr | ₹895 Cr |
Other Long Term Liabilities | ₹75 Cr | ₹75 Cr | ₹46 Cr | ₹35 Cr | ₹90 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹445 Cr | ₹393 Cr | ₹369 Cr | ₹370 Cr | ₹338 Cr |
Total Non-Current Liabilities | ₹2,224 Cr | ₹2,823 Cr | ₹2,238 Cr | ₹2,924 Cr | ₹3,299 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹2,089 Cr | ₹1,679 Cr | ₹1,674 Cr | ₹2,067 Cr | ₹2,049 Cr |
Sundry Creditors | ₹2,089 Cr | ₹1,679 Cr | ₹1,674 Cr | ₹2,067 Cr | ₹2,049 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹1,130 Cr | ₹1,578 Cr | ₹1,365 Cr | ₹1,635 Cr | ₹1,861 Cr |
Bank Overdraft / Short term credit | ₹17 Cr | ₹46 Cr | ₹39 Cr | ₹55 Cr | ₹13 Cr |
Advances received from customers | ₹4.50 Cr | ₹1.33 Cr | ₹10 Cr | ₹8.73 Cr | ₹12 Cr |
Interest Accrued But Not Due | ₹38 Cr | ₹61 Cr | ₹35 Cr | ₹43 Cr | ₹53 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | ₹143 Cr | ₹488 Cr | ₹468 Cr | ₹318 Cr | ₹543 Cr |
Current maturity - Others | - | - | - | - | ₹27 Cr |
Other Liabilities | ₹927 Cr | ₹982 Cr | ₹813 Cr | ₹1,211 Cr | ₹1,213 Cr |
Short Term Borrowings | ₹1,638 Cr | ₹1,765 Cr | ₹923 Cr | ₹704 Cr | ₹1,091 Cr |
Secured ST Loans repayable on Demands | ₹850 Cr | ₹998 Cr | ₹200 Cr | ₹212 Cr | ₹489 Cr |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹788 Cr | ₹767 Cr | ₹723 Cr | ₹492 Cr | ₹602 Cr |
Short Term Provisions | ₹568 Cr | ₹425 Cr | ₹453 Cr | ₹485 Cr | ₹454 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹168 Cr | ₹31 Cr | ₹41 Cr | ₹54 Cr | ₹35 Cr |
Provision for post retirement benefits | ₹3.43 Cr | ₹3.16 Cr | ₹2.90 Cr | ₹2.72 Cr | ₹2.50 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹397 Cr | ₹391 Cr | ₹408 Cr | ₹428 Cr | ₹416 Cr |
Total Current Liabilities | ₹5,425 Cr | ₹5,447 Cr | ₹4,415 Cr | ₹4,892 Cr | ₹5,454 Cr |
Total Liabilities | ₹14,505 Cr | ₹14,468 Cr | ₹12,606 Cr | ₹13,653 Cr | ₹13,577 Cr |
ASSETS | |||||
Gross Block | ₹13,485 Cr | ₹12,812 Cr | ₹10,728 Cr | ₹10,512 Cr | ₹10,334 Cr |
Less: Accumulated Depreciation | ₹5,346 Cr | ₹4,690 Cr | ₹4,306 Cr | ₹3,447 Cr | ₹2,801 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹8,138 Cr | ₹8,121 Cr | ₹6,423 Cr | ₹7,065 Cr | ₹7,533 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹281 Cr | ₹688 Cr | ₹544 Cr | ₹744 Cr | ₹577 Cr |
Non Current Investments | ₹32 Cr | ₹43 Cr | ₹42 Cr | ₹42 Cr | ₹2.09 Cr |
Long Term Investment | ₹32 Cr | ₹43 Cr | ₹42 Cr | ₹42 Cr | ₹2.09 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹32 Cr | ₹43 Cr | ₹42 Cr | ₹42 Cr | ₹2.09 Cr |
Long Term Loans & Advances | ₹349 Cr | ₹181 Cr | ₹167 Cr | ₹97 Cr | ₹222 Cr |
Other Non Current Assets | ₹14 Cr | ₹28 Cr | ₹50 Cr | ₹37 Cr | ₹126 Cr |
Total Non-Current Assets | ₹8,894 Cr | ₹9,139 Cr | ₹7,312 Cr | ₹8,130 Cr | ₹8,596 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹141 Cr | ₹156 Cr | ₹184 Cr | ₹139 Cr | ₹0.02 Cr |
Quoted | ₹0.08 Cr | ₹0.03 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr |
Unquoted | ₹141 Cr | ₹156 Cr | ₹184 Cr | ₹139 Cr | - |
Inventories | ₹2,279 Cr | ₹2,230 Cr | ₹2,462 Cr | ₹2,681 Cr | ₹2,148 Cr |
Raw Materials | ₹643 Cr | ₹752 Cr | ₹841 Cr | ₹985 Cr | ₹741 Cr |
Work-in Progress | ₹141 Cr | ₹116 Cr | ₹178 Cr | ₹180 Cr | ₹203 Cr |
Finished Goods | ₹981 Cr | ₹860 Cr | ₹1,013 Cr | ₹958 Cr | ₹778 Cr |
Packing Materials | ₹61 Cr | ₹57 Cr | ₹58 Cr | ₹59 Cr | ₹49 Cr |
Stores  and Spare | - | - | - | - | - |
Other Inventory | ₹453 Cr | ₹444 Cr | ₹373 Cr | ₹499 Cr | ₹377 Cr |
Sundry Debtors | ₹1,844 Cr | ₹1,944 Cr | ₹1,632 Cr | ₹1,523 Cr | ₹1,649 Cr |
Debtors more than Six months | ₹19 Cr | ₹25 Cr | ₹12 Cr | ₹23 Cr | - |
Debtors Others | ₹1,836 Cr | ₹1,930 Cr | ₹1,628 Cr | ₹1,518 Cr | ₹1,669 Cr |
Cash and Bank | ₹839 Cr | ₹571 Cr | ₹403 Cr | ₹604 Cr | ₹667 Cr |
Cash in hand | ₹0.51 Cr | ₹0.37 Cr | ₹0.30 Cr | ₹0.36 Cr | ₹0.35 Cr |
Balances at Bank | ₹839 Cr | ₹571 Cr | ₹403 Cr | ₹603 Cr | ₹666 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹328 Cr | ₹247 Cr | ₹332 Cr | ₹511 Cr | ₹441 Cr |
Interest accrued on Investments | ₹0.29 Cr | ₹1.93 Cr | ₹0.05 Cr | ₹0.14 Cr | ₹0.32 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹59 Cr | ₹67 Cr | ₹51 Cr | ₹55 Cr | ₹53 Cr |
Other current_assets | ₹269 Cr | ₹178 Cr | ₹280 Cr | ₹456 Cr | ₹388 Cr |
Short Term Loans and Advances | ₹180 Cr | ₹166 Cr | ₹151 Cr | ₹63 Cr | ₹73 Cr |
Advances recoverable in cash or in kind | ₹53 Cr | ₹58 Cr | ₹64 Cr | ₹59 Cr | ₹70 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹127 Cr | ₹107 Cr | ₹88 Cr | ₹4.17 Cr | ₹3.64 Cr |
Total Current Assets | ₹5,611 Cr | ₹5,314 Cr | ₹5,165 Cr | ₹5,522 Cr | ₹4,979 Cr |
Net Current Assets (Including Current Investments) | ₹186 Cr | ₹-134 Cr | ₹750 Cr | ₹630 Cr | ₹-475 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹14,505 Cr | ₹14,468 Cr | ₹12,606 Cr | ₹13,653 Cr | ₹13,577 Cr |
Contingent Liabilities | ₹157 Cr | ₹151 Cr | ₹129 Cr | ₹123 Cr | ₹130 Cr |
Total Debt | ₹3,937 Cr | ₹5,297 Cr | ₹4,018 Cr | ₹4,825 Cr | ₹5,840 Cr |
Book Value | - | 183.13 | 351.75 | 344.90 | 284.99 |
Adjusted Book Value | 202.57 | 183.13 | 175.87 | 172.45 | 142.50 |
Compare Balance Sheet of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹115,201.5 Cr | -0.1% | 0.4% | 75.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹457,025.0 Cr | -2% | 4.3% | 65.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹143,952.0 Cr | -0.5% | 6.4% | 44.2% | Stock Analytics | |
CIPLA | ₹131,056.0 Cr | -2.9% | -1.8% | 39.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,731.0 Cr | -1.8% | -2.2% | 20.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,745.0 Cr | -1.6% | -6.3% | 73.8% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -0.1% |
0.4% |
75.8% |
SENSEX | -5.3% |
-1.6% |
23.1% |
You may also like the below Video Courses